NOTCH1 and colorectal carcinoma: To identify and validate non-genetic potential biomarkers in response to regorafenib, the presence or absence of Notch 1 protein expression in the CRC biopsies was determined by immunohistochemistry, since previous data suggested a key role for Notch 1 in mediating the resistance to regorafenib in CRC cells.